Brilliant Vision with Seanol-P 90c by Progressive Labs
Progressive Labs' Brilliant Vision with Seanol-P 90c is an advanced eye health supplement.* It contains multiple vitamins and nutrients that may both support your eye health and protect it against damaging factors.* This makes it a choice worth considering if you experience vision problems or are afraid of the eye health decline connected to aging.*
Who Should Consider Brilliant Vision with Seanol-P 90c?
Brilliant Vision with Seanol-P 90c may support your health if you:
- are experiencing eye health degeneration related to aging*
- experience night blindness*
- want to support optimum visual functioning*
Brilliant Vision with Seanol-P 90c by Progressive Labs—Effects
Brilliant Vision with Seanol-P 90c by Progressive Labs may:
- support healthy intraocular pressure*
- enhance visual activity*
- promote antioxidation processes and protect you against toxic free radicals*
- prevent and alleviate eye inflammation and fatigue, as well as age-related macular and retinal degeneration, cataracts, glaucoma, myopia, presbyopia and nyctalopia*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about Brilliant Vision with Seanol-P 90c by Progressive Labs.
Recommendation:
Progressive Labs suggests taking 3 Brilliant Vision with Seanol-P capsules daily, with a meal, or as directed by a healthcare professional.
Serving Size: 3 Capsules
Servings Per Container: 30
Amount Per Serving:
Vitamin A 5,000 IU
(as beta carotene with mixed carotenoids from Dunaliella salina)
Vitamin C 45 mg
(as ascorbyl palmitate)
L-Taurine 250 mg
N-Acetyl Carnosine 100 mg
Docosahexanoic Acid
(DHA) 100 mg
Bilberry Extract 100 mg
(fruit)
Eyebright 100 mg
(aerial parts)
Eleuthero Extract 100 mg
(rhizome)
L-Methionine 50 mg
Quercetin 50 mg
Seanol-P Ecklonica Cava Extract 50 mg
R-Lipoic Acid
Grape Seed Extract 25 mg
Ginkgo Leaf Extract 25 mg
Lutein 20 mg
(contains no less than 0.4% Zeaxanthin)
Vinpocetine, BioVinca 10 mg
Zeaxanthin 2 mg
Astaxanthin, AstraREAL 1 mg
Other Ingredients: Rice flour, hypromellose (vegetable capsule).
Keep out of reach of children.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
References:
- Vaneková Z, Rollinger JM. Bilberries: Curative and Miraculous – A Review on Bioactive Constituents and Clinical Research. Front Pharmacol. 2022 Jun 29;13:909914. doi: 10.3389/fphar.2022.909914. PMID: 35847049; PMCID: PMC9277355.
- Riva A, Togni S, Franceschi F, Kawada S, Inaba Y, Eggenhoffner R, Giacomelli L. The effect of a natural, standardized bilberry extract (Mirtoselect®) in dry eye: a randomized, double blinded, placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017 May;21(10):2518-2525. PMID: 28617532.
- Ozawa Y, Kawashima M, Inoue S, Inagaki E, Suzuki A, Ooe E, Kobayashi S, Tsubota K. Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. J Nutr Health Aging. 2015 May;19(5):548-54. doi: 10.1007/s12603-014-0573-6. PMID: 25923485.
- Yu WY, Chan LYL, Chung A, Lee PH, Woo GC. Bilberry-containing supplements on severe dry eye disease in young and middle-aged adults: A 3-month pilot analysis. Front Nutr. 2023 Jan 19;10:1061818. doi: 10.3389/fnut.2023.1061818. PMID: 36742436; PMCID: PMC9892183.
- Lans C, Georges K, Brown G. Non-experimental validation of ethnoveterinary plants and indigenous knowledge used for backyard pigs and chickens in Trinidad and Tobago. Trop Anim Health Prod. 2007 Jun;39(5):375-85. doi: 10.1007/s11250-007-9026-0. PMID: 17944308.
- Stoss M, Michels C, Peter E, Beutke R, Gorter RW. Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis. J Altern Complement Med. 2000 Dec;6(6):499-508. doi: 10.1089/acm.2000.6.499. PMID: 11152054.
- Bigagli E, Cinci L, D’Ambrosio M, Luceri C. Pharmacological activities of an eye drop containing Matricaria chamomilla and Euphrasia officinalis extracts in UVB-induced oxidative stress and inflammation of human corneal cells. J Photochem Photobiol B. 2017 Aug;173:618-625. doi: 10.1016/j.jphotobiol.2017.06.031. Epub 2017 Jun 24. PMID: 28704790.
- Analysis of functional components and radical scavenging activity of 21 algae species collected from the Japanese coast. Ito M, Koba K, Hikihara R, Ishimaru M, Shibata T, Hatate H, Tanaka R.
- The cytoprotective effects of ethanol extract of Ecklonia cava against oxidative stress are associated with upregulation of Nrf2-mediated HO-1 and NQO-1 expression through activation of the MAPK pathway. Choi YH.
- Nivison-Smith L, Khoo P, Acosta ML, Kalloniatis M. Pre-treatment with vinpocetine protects against retinal ischemia. Exp Eye Res. 2017 Jan;154:126-138. doi: 10.1016/j.exer.2016.11.018. Epub 2016 Nov 27. PMID: 27899287.
- Lisa Nivison-Smith, Pauline Khoo, Monica L. Acosta, Michael Kalloniatis, Vinpocetine protects inner retinal neurons with functional NMDA glutamate receptors against retinal ischemia, Experimental Eye Research, Volume 167, 2018, Pages 1-13, ISSN 0014-4835, https://doi.org/10.1016/j.exer.2017.10.008.
- Dubois VD, Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract. Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009493. doi: 10.1002/14651858.CD009493.pub2. PMID: 28245346; PMCID: PMC6464029.
- Babizhayev MA, Burke L, Micans P, Richer SP. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population. Clin Interv Aging. 2009;4():31-50. Epub 2009 May 14. PMID: 19503764; PMCID: PMC2685223.
- Babizhayev MA, Deyev AI, Yermakova VN, et al. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D. 2002;3(2): 87-103.